Santé log2d
EnnoDC presents positive Phase I data at CROI 2025, demonstrating long-lasting immunity induced by Antibody Mediated Vaccines (AMVs)
EnnoDC presents positive Phase I data at CROI 2025, demonstrating long-lasting immunity induced by Antibody Mediated Vaccines (AMVs) Findings in HIV highlight AMV technology's versatility, robust ...
Santé log2d
Salipro Biotech and Boehringer Ingelheim Enter Research and License Agreement to Accelerate Multiple Boehringer Ingelheim Pipeline Programs
The collaboration combines Salipro Biotech’s unique expertise and its Salipro® platform technology to stabilise challenging drug targets from Boehringer Ingelheim’s drug discovery programs to enable ...
Santé log2d
Virbac: Communiqué de mise à disposition des comptes consolidés au 31 décembre 2024
Communiqué de mise à disposition des comptes consolidés au 31 décembre 2024. Le Groupe annonce avoir mis à la disposition du public ses comptes consolidés au 31 décembre 2024 sur le site internet du G ...
Santé log2d
Medigene Files Patent for Unique NK-Specific TCR Construct with European Patent Office
To enable this innovation, Medigene combined TCR-guided precision targeting with innate NK cell killing. The Company has developed a proprietary universal scaffold that allows its 3S TCRs to function ...
Santé log2d
PALTmed & LTC ACO Launch Value-Based Care Joint Alliance
LTC ACO is the first Accountable Care Organization (ACO) in the United States dedicated to long-term care facility residents. LTC ACO began participating in the Medicare Shared Savings Program (MSSP) ...
Santé log2d
Aclarion Provides Shareholder Update
The Company intends on filing its 10K by the end of March and plans to provide a more in-depth Corporate Update at that time. About Aclarion, Inc.
Santé log2d
Pills2Me Reaches One Million Prescription Deliveries Milestone and Announces Nationwide Launch
Pills2Me, the rapidly growing on-demand prescription delivery service, today announced its nationwide rollout, set to begin in Q2 of 2025. This ambitious expansion follows a major milestone of ...
Santé log2d
Zeranovia(TM) Weight Loss Product Shows Promising Results in Dosage Trial
LAS VEGAS, March 13, 2025 (GLOBE NEWSWIRE) -- via IBN -- BioAdaptives Inc. (OTC: BDPT) today announced the successful completion of dosage trials for its innovative weight loss product, Zeranovia™.
Santé log2d
FDA Issues Clearance for ReWalk 7 Exoskeleton
Seventh Generation of Industry-Leading Exoskeleton Includes New and Enhanced Features for Individuals with Spinal Cord Injury ...
Santé log2d
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 28 février 2025
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 28 février 2025 ...
Santé log3d
CANNABIS : Ses terpènes contre la fibromyalgie
Les terpènes du cannabis sativa offrent une nouvelle approche thérapeutique possible pour traiter les douleurs associées à la ...
Santé log3d
Bioxytran Develops a Groundbreaking Treatment to Combat Bird Flu in Egg Laying Chickens Potentially Saving Billions
(OTCQB: BIXT) (the “Company”), a clinical stage biotechnology company developing oral and intravenous drugs to treat viral diseases, unveiled a potential game-changer in the fight against Highly ...